These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 22966957

  • 1. [(99m)Tc]Demomedin C, a radioligand based on human gastrin releasing peptide(18-27): synthesis and preclinical evaluation in gastrin releasing peptide receptor-expressing models.
    Nock BA, Cescato R, Ketani E, Waser B, Reubi JC, Maina T.
    J Med Chem; 2012 Oct 11; 55(19):8364-74. PubMed ID: 22966957
    [Abstract] [Full Text] [Related]

  • 2. 99mTc radiotracers based on human GRP(18-27): synthesis and comparative evaluation.
    Marsouvanidis PJ, Maina T, Sallegger W, Krenning EP, de Jong M, Nock BA.
    J Nucl Med; 2013 Oct 11; 54(10):1797-803. PubMed ID: 24009275
    [Abstract] [Full Text] [Related]

  • 3. New Gastrin Releasing Peptide Receptor-Directed [99mTc]Demobesin 1 Mimics: Synthesis and Comparative Evaluation.
    Nock BA, Charalambidis D, Sallegger W, Waser B, Mansi R, Nicolas GP, Ketani E, Nikolopoulou A, Fani M, Reubi JC, Maina T.
    J Med Chem; 2018 Apr 12; 61(7):3138-3150. PubMed ID: 29517903
    [Abstract] [Full Text] [Related]

  • 4. [99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging.
    Nock B, Nikolopoulou A, Chiotellis E, Loudos G, Maintas D, Reubi JC, Maina T.
    Eur J Nucl Med Mol Imaging; 2003 Feb 12; 30(2):247-58. PubMed ID: 12552343
    [Abstract] [Full Text] [Related]

  • 5. Radiochemical investigations of gastrin-releasing peptide receptor-specific [(99m)Tc(X)(CO)3-Dpr-Ser-Ser-Ser-Gln-Trp-Ala-Val-Gly-His-Leu-Met-(NH2)] in PC-3, tumor-bearing, rodent models: syntheses, radiolabeling, and in vitro/in vivo studies where Dpr = 2,3-diaminopropionic acid and X = H2O or P(CH2OH)3.
    Smith CJ, Sieckman GL, Owen NK, Hayes DL, Mazuru DG, Kannan R, Volkert WA, Hoffman TJ.
    Cancer Res; 2003 Jul 15; 63(14):4082-8. PubMed ID: 12874010
    [Abstract] [Full Text] [Related]

  • 6. Tetraamine-derived bifunctional chelators for technetium-99m labelling: synthesis, bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-positive tumours.
    Abiraj K, Mansi R, Tamma ML, Forrer F, Cescato R, Reubi JC, Akyel KG, Maecke HR.
    Chemistry; 2010 Feb 15; 16(7):2115-24. PubMed ID: 20066690
    [Abstract] [Full Text] [Related]

  • 7. Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [⁶⁸Ga]SB3 and PET/CT.
    Maina T, Bergsma H, Kulkarni HR, Mueller D, Charalambidis D, Krenning EP, Nock BA, de Jong M, Baum RP.
    Eur J Nucl Med Mol Imaging; 2016 May 15; 43(5):964-973. PubMed ID: 26631238
    [Abstract] [Full Text] [Related]

  • 8. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.
    Santos-Cuevas CL, Ferro-Flores G, Arteaga de Murphy C, Ramírez Fde M, Luna-Gutiérrez MA, Pedraza-López M, García-Becerra R, Ordaz-Rosado D.
    Int J Pharm; 2009 Jun 22; 375(1-2):75-83. PubMed ID: 19393305
    [Abstract] [Full Text] [Related]

  • 9. Organometallic 99mTc(III) '4 + 1' bombesin(7-14) conjugates: synthesis, radiolabeling, and in vitro/in vivo studies.
    Kunstler JU, Veerendra B, Figueroa SD, Sieckman GL, Rold TL, Hoffman TJ, Smith CJ, Pietzsch HJ.
    Bioconjug Chem; 2007 Jun 22; 18(5):1651-61. PubMed ID: 17663527
    [Abstract] [Full Text] [Related]

  • 10. Radiochemical investigations of (99m)Tc-N(3)S-X-BBN[7-14]NH(2): an in vitro/in vivo structure-activity relationship study where X = 0-, 3-, 5-, 8-, and 11-carbon tethering moieties.
    Smith CJ, Gali H, Sieckman GL, Higginbotham C, Volkert WA, Hoffman TJ.
    Bioconjug Chem; 2003 Jun 22; 14(1):93-102. PubMed ID: 12526698
    [Abstract] [Full Text] [Related]

  • 11. Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies.
    Faintuch BL, Teodoro R, Duatti A, Muramoto E, Faintuch S, Smith CJ.
    Nucl Med Biol; 2008 May 22; 35(4):401-11. PubMed ID: 18482677
    [Abstract] [Full Text] [Related]

  • 12. Potent bombesin-like peptides for GRP-receptor targeting of tumors with 99mTc: a preclinical study.
    Nock BA, Nikolopoulou A, Galanis A, Cordopatis P, Waser B, Reubi JC, Maina T.
    J Med Chem; 2005 Jan 13; 48(1):100-10. PubMed ID: 15634004
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors.
    Okarvi SM, Al Jammaz I.
    Nucl Med Biol; 2010 Apr 13; 37(3):277-88. PubMed ID: 20346867
    [Abstract] [Full Text] [Related]

  • 14. Impact of functionalized coligands on the pharmacokinetics of 99mTcIII '4+1' mixed-ligand complexes conjugated to bombesin.
    Kunstler JU, Bergmann R, Gniazdowska E, Koźmiński P, Walther M, Pietzsch HJ.
    J Inorg Biochem; 2011 Nov 13; 105(11):1383-90. PubMed ID: 21946438
    [Abstract] [Full Text] [Related]

  • 15. microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.
    Chen X, Park R, Hou Y, Tohme M, Shahinian AH, Bading JR, Conti PS.
    J Nucl Med; 2004 Aug 13; 45(8):1390-7. PubMed ID: 15299066
    [Abstract] [Full Text] [Related]

  • 16. Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumors.
    Abiraj K, Mansi R, Tamma ML, Fani M, Forrer F, Nicolas G, Cescato R, Reubi JC, Maecke HR.
    J Nucl Med; 2011 Dec 13; 52(12):1970-8. PubMed ID: 22080443
    [Abstract] [Full Text] [Related]

  • 17. Preparation and evaluation of 99mTc-EDDA/HYNIC-[Lys 3]-bombesin for imaging gastrin-releasing peptide receptor-positive tumours.
    Ferro-Flores G, Arteaga de Murphy C, Rodriguez-Cortés J, Pedraza-López M, Ramírez-Iglesias MT.
    Nucl Med Commun; 2006 Apr 13; 27(4):371-6. PubMed ID: 16531924
    [Abstract] [Full Text] [Related]

  • 18. Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells.
    Smith CJ, Gali H, Sieckman GL, Hayes DL, Owen NK, Mazuru DG, Volkert WA, Hoffman TJ.
    Nucl Med Biol; 2003 Feb 13; 30(2):101-9. PubMed ID: 12623108
    [Abstract] [Full Text] [Related]

  • 19. PEGylation of (99m)Tc-labeled bombesin analogues improves their pharmacokinetic properties.
    Däpp S, García Garayoa E, Maes V, Brans L, Tourwé DA, Müller C, Schibli R.
    Nucl Med Biol; 2011 Oct 13; 38(7):997-1009. PubMed ID: 21982571
    [Abstract] [Full Text] [Related]

  • 20. (99m)technetium-HYNIC(tricine/TPPTS)-Aca-bombesin(7-14) as a targeted imaging agent with microSPECT in a PC-3 prostate cancer xenograft model.
    Ananias HJ, Yu Z, Dierckx RA, van der Wiele C, Helfrich W, Wang F, Yan Y, Chen X, de Jong IJ, Elsinga PH.
    Mol Pharm; 2011 Aug 01; 8(4):1165-73. PubMed ID: 21699202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.